DUBLIN--(BUSINESS WIRE)--The "Small Molecule API Contract Manufacturer Quality Benchmarking (2nd edition)" report has been added to Research and Markets' offering. As pharmaceutical and ...
Wilmington PharmaTech (“Wilmington”), a leading U.S.-based research, development, and manufacturing organization (CRDMO) ...
DUBLIN--(BUSINESS WIRE)--The "Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Market Growth Opportunities, 2023" report has been added to ResearchAndMarkets.com's ...
Through the partnership, SK pharmteco will gain access to Prozomix’s complete “Biocatalysis Enzyme Toolkit,” which features over 6,000 diverse native biocatalysts. This access allows SK pharmteco to ...
Arul Ramadurai, CCO, Axplora, discusses the company’s investment in expanding its HPAPI development and manufacturing ...
This month, the Joe Biden administration awarded $14 million to the API Innovation Center, a Saint Louis–based nonprofit that aims to remedy supply chain problems for active pharmaceutical ingredients ...
Raubling, Germany-based Axplora, which focuses on small-molecule API manufacturing reports that its total investments initiated across its global network in 2025 will exceed €100 million ($115.6 ...
Teva announced its intention to divest its active-pharmaceutical ingredient business, or "TAPI". TAPI is a global leader in the small-molecule API industry, with approximately 4,300 employees ...
Teva (NYSE:TEVA) plans to divest its active-pharmaceutical ingredient (API) business as part of its Pivot to Growth strategy to focus on its core business strengths. "The intent to divest TAPI will ...
As the science of drug discovery has grown in scale and gotten more complicated, so have the drug molecules themselves. But there’s a promising class of drugs made of just a handful of atoms that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results